Mario Presti

Medical Student exploring Cancer Immunology research with the employment of computational strategies. Visiting student at the Broad Institute of MIT and Harvard

[Mario Presti @MarioPre_]

@Akira_Ishige Hi Akira, I am the guitar player! Thanks a lot!! We love your songs guys 🤟

[石毛輝 Akira Ishige @Akira_Ishige]

ヤバい、デンマークいきたい

[Marco Donia @DoniaMarco]

🌟 Did you know CD4+ T cells can kill #immunotherapy-resistant #cancer?
👉 https://t.co/mPj9S5npwN published by
@CCR_AACR

🎯 We revealed a new approach that may overcome some immune checkpoint blockade (ICB)-resistant tumors by harnessing CD4+ T cells

#TILs #Melanoma

[Marco Donia @DoniaMarco]

**Acquired resistance to #melanoma Immunotherapy**

Approx. 30% of patients with #melanoma who initially respond to #Immunotherapy later progress. Knowledge of molecular mechanisms helps develop new treatments for this major challenge in #oncology

[Marco C. @mark_wagon]

Transparency in science is key 🔑 I'm glad to see the academic community working towards a more transparent and fair peer-review process #OpenScience #Transparency #PeerReview @NatureComms https://t.co/BXcHjqxsqQ

[Cancer Discovery @CD_AACR]

In the January issue of Cancer Discovery—
Molecular Characterization of Acquired Resistance to #KRAS G12C-#EGFR Inhibition in #ColorectalCancer, by @RonaYaeger, @Sandra_Misale et al.
https://t.co/AIWMWDSW4Q
@MSKCancerCenter

[Dr Max Julvé @JulveMax]

Thank-you to @myESMO for organising a fantastic immunotherapy preceptorship- great meeting fellow IO enthusiasts from across Europe! @p_ciracimd @nasca_vincenzo @A_DAlessioMD @MarioPre_ 🇮🇹 among others!

[Mario Presti @MarioPre_]

Excited to share our work recently published in @CIR_AACR! Find out how #melanoma #cancer cells can become invisible to #Tcell immunity.
@CCITdk @DoniaMarco @AriannaDraghi @CAChamberlain_ @Michael44364760

[Cancer Immunology Research @CIR_AACR]

Check out how #melanoma acquires resistance to multiple lines of #immunotherapy by gaining consecutive alterations, resulting in pan T-cell immune escape. By Nielsen, @MarioPre_, Svane, @DoniaMarco et al.
https://t.co/Ww9FZlzRew
@AriannaDraghi @CAChamberlain_ @Michael44364760

[CCIT-DK: National Center for Cancer Immune Therapy @CCITdk]

Successful #phd defenses from @CAChamberlain_ on "Identification, characterization and manipulation of #tumor-reactive #Tcells" and Astrid Zedlitz Johansen on "YKL-40: A #Cancer target and #biomarker?"

[Marco Donia @DoniaMarco]

Particle air pollution and how it works

[CCIT-DK: National Center for Cancer Immune Therapy @CCITdk]

Live from #ESMO22 ! @myESMO

[CCIT-DK: National Center for Cancer Immune Therapy @CCITdk]

The first T cell #immunotherapy phase 3 clinical trial in solid tumors to be presented at #ESMO22, Presidential Symposium I today at 17:20. Potentially practice changing results in #melanoma from @NKI_nl and @CCITdk! @myESMO @HaanenJohn
@DoniaMarco https://t.co/sOuVyqL0UR

[CCIT-DK: National Center for Cancer Immune Therapy @CCITdk]

@CCITdk well represented at #EACR2022 by the TSMI and the TIL groups! @CAChamberlain_ @shawezkhanalig @AriannaDraghi @MarioPre_ @DanielHMadsen @DoniaMarco

[Marco Donia @DoniaMarco]

If you are a #ukrainian 🇺🇦 scientist with interest in #cancer research or #oncologist, please feel free to contact me if you need any kind of support e.g. getting in touch with labs or hospitals in Denmark🇩🇰 or other #ScienceForUkraine @Sci_for_Ukraine

[Mario Presti @MarioPre_]

@Nature @DoniaMarco

[Marco Donia @DoniaMarco]

@GiorgiaMeloni @FratellidItalia Wow, I guess the "clinical evidence" you are referring to is reported in Meloni et al. 2021, published in the @NEJM ?

[CCIT-DK: National Center for Cancer Immune Therapy @CCITdk]

Congratulations to our collegues Morten Holmström and Anders Kverneland. Both were awarded a BRIDGE fellowship. https://t.co/VlRWyckyHh

[Mario Presti @MarioPre_]

@biorxiv_sysbio @EmanueleChisari